Inventor · disambiguated record
Douglas C. Behenna
Also filed as: BEHENNA DOUGLAS · BEHENNA DOUGLAS C · BEHENNA DOUGLAS CARL
17 granted patents·10 pending applications·70 citations·filing 2005–2024
92Inventor score
Top patents by PatentIndex Score
27 records- 0197US11014911B2CDK2 inhibitorsPFIZER·Filed 2020·Granted May 25, 2021·11 cites·4 claims
- 0295US11718603B2CDK2 inhibitorsPFIZER·Filed 2021·Granted Aug 8, 2023·3 cites·21 claims
- 0394US10035769B2Quaternary heteroatom containing compoundsCALIFORNIA INST OF TECHN·Filed 2016·Granted Jul 31, 2018·9 cites·19 claims
- 0493US11773082B2CDK2 inhibitorsPFIZER·Filed 2021·Granted Oct 3, 2023·2 cites·25 claims
- 0593US10343996B2Quaternary heteroatom containing compoundsCALIFORNIA INST OF TECHN·Filed 2018·Granted Jul 9, 2019·6 cites·11 claims
- 0692US11691979B2Imidazopyridazines as modulators of IL-17JANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jul 4, 2023·3 cites·47 claims
- 0791US11702422B2Imidazopyridazines as modulators of IL-17JANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jul 18, 2023·2 cites·24 claims
- 0891US10906875B2Quaternary heteroatom containing compoundsCALIFORNIA INST OF TECHN·Filed 2019·Granted Feb 2, 2021·4 cites·5 claims
- 0991US8822679B2Quaternary heteroatom containing compoundsSTOLTZ BRIAN M·Filed 2012·Granted Sep 2, 2014·14 cites·16 claims
- 1088US12024524B2Imidazopyridazines as modulators of IL-17JANSSEN PHARMACEUTICA NV·Filed 2023·Granted Jul 2, 2024·1 cites·20 claims
- 1186US7235698B2Enantioselective, catalytic allylation of ketones and olefinsCALIFORNIA INST OF TECHN·Filed 2005·Granted Jun 26, 2007·14 cites·85 claims
- 1281US2024294506A1Cdk2 inhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 1379US2023098847A1Quaternary heteroatom containing compoundsCALIFORNIA INST OF TECHN·Filed 2022·Application pending·0 cites
- 1475US2022324872A1CDK2/4/6 InhibitorsPFIZER·Filed 2022·Application pending·0 cites
- 1573US12215111B2Imidazopyridazine IL-17 inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Feb 4, 2025·0 cites·24 claims
- 1673US11390585B2Quaternary heteroatom containing compoundsCALIFORNIA INST OF TECHN·Filed 2021·Granted Jul 19, 2022·0 cites·14 claims
- 1770US2025206744A1Imidazopyridazine il-17 inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1868US9290496B2Purine derivativesPFIZER·Filed 2014·Granted Mar 22, 2016·1 cites·11 claims
- 1967US11396512B2CDK2/4/6 inhibitorsPFIZER·Filed 2020·Granted Jul 26, 2022·0 cites·12 claims
- 2067US10800783B2CDK2/4/6 inhibitorsPFIZER·Filed 2019·Granted Oct 13, 2020·0 cites·16 claims
- 2164US2013267699A1Quaternary heteroatom containing compoundsCALIFORNIA INST OF TECHN·Filed 2013·Application pending·0 cites
- 2263US2025109137A1Imidazopyridazine il-17 inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2358US2024376085A1Benzimidazoles as modulators of il-17JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2458US2025122181A1Benzimidazoles as modulators of il-17JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2552US11203594B2Anti-proliferative agents for treating PAHPFIZER·Filed 2020·Granted Dec 21, 2021·0 cites·30 claims
- 2641US2022127262A1Crystalline form of a cdk inhibitorPFIZER·Filed 2020·Application pending·0 cites
- 2732US2016096810A1Enantioselective synthesis of dialkylated n,o-heterocycles by palladium-catalyzed allylic alkylationSTOLTZ BRIAN M·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Douglas C. Behenna files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →